18 Mar 2024 Following the positive profi
CROSBY Research – Wasion Holdings (3393 HK/BUY): Strong FY23 NP growth on solid revenue growth and GPM improvement
CROSBY Research – Giordano (709 HK): FY23 NP rose by 29% YoY on higher GPM and operating leverage
18 Mar 2024 FY23 revenue slightly increa
CROSBY Research – 361 Degrees (1361 HK/BUY): Solid FY23 results with strong growth from Kids and online segments
14 Mar 2024 FY23 revenue was up 21.0% Yo
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 54)
11 Mar 2024 (Bloomberg) Hong Kong’s 10 b
CROSBY Research – Concord (182 HK/BUY): Solid FY23 results
08 Mar 2024 CNE’s FY23 revenue was up by
CROSBY Research – JNBY (3306 HK): Net profit increased by 55% YoY on better margins
01 Mar 2024 JNBY announced its FY1H24 in
CROSBY Research – Pentamaster International (1665 HK/BUY): Steady 4Q23 revenue growth and GPM expansion; medical devices segment remains key growth driver in FY24
01 Mar 2024 Pentamaster’s 4Q23 revenue i
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 53)
26 Feb 2024 2023 the global economic act
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 52)
06 Feb 2024 Under a so-called “whi
CROSBY Research – Vincent Medical (1612 HK/BUY): Turnaround in FY23
02 Feb 2024 Vincent Medical (VM) issued